- Effects of Atorvastatin in Patients with Acute Spinal Cord Injury
-
Aghazadeh , Samadi Motlagh P, Salehpour , Meshkini A, Fatehi M, Mirzaei F, Naseri Alavi SA
- KMID: 2397628
- Asian Spine J.
- 2017 Dec;11(6):903-907.
- doi: 10.4184/asj.2017.11.6.903
STUDY DESIGN: Clinical trial study. PURPOSE: The aim of this study was to evaluate the effect of atorvastatin on sensory and motor function in patients with acute spinal cord injury. OVERVIEW OF... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of short-term atorvastatin use in patients with calcium stones: A randomized placebo-controlled clinical trial
-
Taheri F, Taheri M, Basiri A, Khoshdel A, Samadian F, Tavasoli S
- KMID: 2461059
- Investig Clin Urol.
- 2019 Nov;60(6):472-479.
- doi: 10.4111/icu.2019.60.6.472
PURPOSE: A few experimental and observational studies have reported that atorvastatin prevents calcium oxalate stone formation. Our study is the first to investigate the effect of atorvastatin on 24-hour urinary... -
- CITED
-
- Close
- SHARE
-
- Close
- Visual Field Defect after Taking Atorvastatin/Ezetimibe, a Case Study
-
Kim J, Lee K, Kim J, Lee JM, Kim NY, Lee MS, Ji E
- KMID: 2452862
- Korean J Clin Pharm.
- 2019 Jun;29(2):133-137.
- doi: 10.24304/kjcp.2019.29.2.133
Atorvastatin is one of the most widely prescribed medications for dyslipidemia treatment. In Korea, post combined therapy with ezetimibe, a 73-year-old woman was reported by a community pharmacy to have... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
-
Han E, Kim G, Lee JY, Lee YH, Kim BS, Lee BW, Cha BS, Kang ES
- KMID: 2384087
- Endocrinol Metab.
- 2017 Jun;32(2):274-280.
- doi: 10.3803/EnM.2017.32.2.274
BACKGROUND: Although the beneficial effects of statin treatment in dyslipidemia and atherosclerosis have been well studied, there is limited information regarding the renal effects of statins in diabetic nephropathy. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: A Retrospective Study on the Efficacy of a Ten-Milligram Dosage of Atorvastatin for Treatment of Hypercholesterolemia in Type 2 Diabetes Mellitus Patients (Korean Diabetes J 2010;34:359-67)
-
Rhee EJ
- KMID: 2281497
- Diabetes Metab J.
- 2011 Feb;35(1):86-87.
- doi: 10.4093/dmj.2011.35.1.86
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Atorvastatin pretreatment attenuates kainic acid-induced hippocampal neuronal death via regulation of lipocalin-2-associated neuroinflammation
-
Jin Z, Jung Y, Yi CO, Lee JY, Jeong EA, Lee JE, Park KJ, Kwon OY, Lim BH, Choi NC, Roh GS
- KMID: 2410094
- Korean J Physiol Pharmacol.
- 2018 May;22(3):301-309.
- doi: 10.4196/kjpp.2018.22.3.301
Statins mediate vascular protection and reduce the prevalence of cardiovascular diseases. Recent work indicates that statins have anticonvulsive effects in the brain; however, little is known about the precise mechanism... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
-
Park J, Kim CO, Jin BH, Yang S, Park MS, Hong T
- KMID: 2407003
- Transl Clin Pharmacol.
- 2017 Dec;25(4):202-208.
- doi: 10.12793/tcp.2017.25.4.202
Atorvastatin and ezetimibe are frequently co-administered to treat patients with dyslipidemia for the purpose of low-density lipoprotein cholesterol control. However, pharmacokinetic (PK) drug interaction between atorvastatin and ezetimibe has not... -
- CITED
-
- Close
- SHARE
-
- Close
- Economic Evaluation of Rosuvastatin and Atorvastatin for the Treatment of Dyslipidemia from a Korean Health System Perspective
-
Suh S, Jung CH, Hong SJ, Kim JS, Song BJ, Sohn HS, Choi SH
- KMID: 2328839
- J Lipid Atheroscler.
- 2016 Jun;5(1):61-77.
- doi: 10.12997/jla.2016.5.1.61
OBJECTIVE: This study aims to analyze cost-effectiveness of two most-commonly used statins from the perspective of the Korean national health system. METHODS: The scope of the analysis included rosuvastatin (5 mg,... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetics of atorvastatin and sustained-release metformin fixed-dose combination tablets: two randomized, open-label, 2-way crossover studies in healthy male subjects under fed conditions
-
Choi YK, Park SE, Kim EY, Park HJ, Kim EJ, Song GS, Ghim JL
- KMID: 2407001
- Transl Clin Pharmacol.
- 2017 Dec;25(4):190-195.
- doi: 10.12793/tcp.2017.25.4.190
Two separate studies were conducted to establish bioequivalence (BE) for two doses of atorvastatin/metformin sustained-release (SR) fixed dose combination (FDC) versus the same dosage of the individual component (IC) tablets... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
-
Kim JM, Back MK, Yi HS, Joung KH, Kim HJ, Ku BJ
- KMID: 2383317
- Diabetes Metab J.
- 2016 Feb;40(1):70-78.
- doi: 10.4093/dmj.2016.40.1.70
BACKGROUND: Elevated serum levels of growth differentiation factor-15 (GDF-15) are associated with type 2 diabetes. Therefore, the effects of atorvastatin on metabolic parameters and GDF-15 levels in patients with type... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of 20 mg/day Atorvastatin: Recurrent Stroke Survey in Chinese Ischemic Stroke Patients with Prior Intracranial Hemorrhage
-
Jia W, Zhou L
- KMID: 2287551
- J Clin Neurol.
- 2013 Jul;9(3):139-143.
- doi: 10.3988/jcn.2013.9.3.139
BACKGROUND AND PURPOSE: Treatment with atorvastatin (80 mg) in stroke secondary prevention for patients with prior intracranial hemorrhage (ICH) has been associated with a higher frequency of ICH. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Rhabdomyolysis in a Cyclosporine-treated Renal Transplant Recipient Who Received Atorvastatin as Replacement for Fluvastatin
-
Lee WB, Park JW, Song MS, Park MY, Cho YK, Jeung BY, Gil HW, Yang JO, Lee EY, Hong SY
- KMID: 2307273
- Korean J Nephrol.
- 2004 Sep;23(5):836-839.
Statin-induced rhabdomyolysis is a frequent complication in renal transplant recipients receiving cyclosporine, but incidences are different between different types of statins. Statins have different pharmacokinetic properties. Atorvsatatin, simvastatin, lovastatin, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
-
Park JH, Lee YH, Ko SK, Cha BS
- KMID: 2380647
- Epidemiol Health.
- 2015;37:e2015010.
- doi: 10.4178/epih/e2015010
OBJECTIVES: Single-pill combination therapy (amlodipine/atorvastatin) might be more effective than double-pill therapy (amlodipine+atorvastatin) in patients with diabetes and concomitant hypertension requiring statin therapy. We compared the cost-effectiveness of a single-pill... -
- CITED
-
- Close
- SHARE
-
- Close
- Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis
-
Lee WS, Lee EG, Sung MS, Choi YJ, Yoo WH
- KMID: 2411552
- Korean J Intern Med.
- 2018 Mar;33(2):397-406.
- doi: 10.3904/kjim.2015.244
BACKGROUND/AIMS: To define the effect of statins on interleukin 1β (IL-1β)-induced osteoclastogenesis and elucidate the underlying mechanisms. METHODS: Bone marrow cells were obtained from 5-week-old male ICR (Institute for Cancer Research)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Pioglitazone in Combination with Moderate Dose Statin on Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using Serial FDG-PET/CT
-
Choo EH, Han EJ, Kim CJ, Kim SH, O JH, Chang K, Seung KB
- KMID: 2414893
- Korean Circ J.
- 2018 Jul;48(7):591-601.
- doi: 10.4070/kcj.2017.0029
BACKGROUND AND OBJECTIVES: Non-statin therapy plus lower intensity statin might be an alternative in patients with coronary artery disease (CAD). A recent data suggested an anti-inflammatory therapy can reduce recurrent... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Atorvastatin on the Induction of Experimental Cerebral Aneurysm in a High Lipid Diet Rat Model
-
Lim JK, Yeo IS, Yi JS, Lee HJ, Yang JH, Lee IW
- KMID: 2256704
- Korean J Cerebrovasc Surg.
- 2010 Sep;12(3):196-201.
OBJECTIVE: Previously, we reported that a high lipid diet significantly increases the induction rate of cerebral aneurysm (CA) formation in an experimentally induced CA rat model, suggesting that hypercholesterolemia with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Composition of Pharmaceutical Expenditure in National Health Insurance and Implications for Reasonable Spending
-
Lee HJ
- KMID: 2438587
- Health Policy Manag.
- 2018 Dec;28(4):360-368.
- doi: 10.4332/KJHPA.2018.28.4.360
BACKGROUND: The proportion of pharmaceutical expenditure out of total health-care expenditure in South Korea is high. In 2016, 25.7% of national health insurance (NHI) spending was for pharmaceuticals. Given the... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Atorvastatin, a HMG-CoA Reductase Inhibitor, in Experimental Colitis in Mice
-
Park HJ, Kim TW, Seo JN, Oh KI, Choi EY, Shin HS, Park YE
- KMID: 2277695
- Korean J Pathol.
- 2004 Dec;38(6):401-407.
BACKGROUND: The statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are approved for cholesterol reduction, and may also be beneficial in the treatment of inflammatory disease. In this study, atorvastatin was tested... -
- CITED
-
- Close
- SHARE
-
- Close
- Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy
-
Basyoni MM, Fouad SA, Amer MF, Amer AF, Ismail DI
- KMID: 2412728
- Korean J Parasitol.
- 2018 Apr;56(2):105-112.
- doi: 10.3347/kjp.2018.56.2.105
Blastocystis is an enteric Straminopile in tropical, subtropical and developing countries. Metronidazole has been a chemotheraputic for blastocystosis. Failures in its regimens were reported and necessitate new studies searching for... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of High-dose Atorvastatin Pretreatment in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Study
-
Kim EK, Hahn JY, Song YB, Chang SA, Choi JH, Choi SH, Lee SC, Choe YH, Lee SH, Gwon HC
- KMID: 2164451
- J Korean Med Sci.
- 2015 Apr;30(4):435-441.
- doi: 10.3346/jkms.2015.30.4.435
It is uncertain that atorvastatin pretreatment can reduce myocardial damage in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
